Hexal Australia Pty Ltd v Roche Therapeutics Inc [2005] FCA 1218

Hexal Australia Pty Ltd v Roche Therapeutics Inc [2005] FCA 1218

Although there is a serious question to be tried in relation to patent infringement and validity, Roche failed to establish that damages would be inadequate if relief was refused, and balance of convenience favours refusal of interlocutory relief. Therefore, interlocutory injunctions sought by Roche against Hexal and Alphapharm are refused.

Jurisdiction
Australia
Judgment Date
31 August 2005
Procedural Posture
Patent Litigation Interlocutory Applications / Interlocutory Applications for Injunctions; Judgment at Interlocutory Stage
Outcome
Interlocutory injunctions/applications for interlocutory relief refused; Hexal's notice of motion dismissed; application for relief against Alphapharm refused.
Legal Topics
['interlocutory Injunctions' 'patent Infringement' 'patent Validity' 'novelty' 'obviousness' 'fair Basis' 'pharmaceuticals' 'pbs Listing']
['intellectual Property Law' 'patent Law'] ['interlocutory Injunctions' 'patent Infringement' 'patent Validity' 'novelty' 'obviousness' 'fair Basis' 'pharmaceuticals' 'pbs Listing']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Patent Litigation Interlocutory Applications / Interlocutory Applications for Injunctions; Judgment at Interlocutory Stage

Legal Issues

  1. 1 ['Whether interlocutory injunction should be granted to restrain threatened infringement of patent' 'Whether there is a serious question to be tried regarding infringement and validity of the patent' 'Whether infringement of manufacture claims and method claims is established or triable' 'Whether claims lack novelty, obviousness, or fair basis under Patents Act' 'Whether damages would be adequate compensation or irreparable harm would arise absent injunctive relief' 'Balance of convenience between parties']

Ratio Decidendi

Although there is a serious question to be tried in relation to patent infringement and validity, Roche failed to establish that damages would be inadequate if relief was refused, and balance of convenience favours refusal of interlocutory relief. Therefore, interlocutory injunctions sought by Roche against Hexal and Alphapharm are refused.

Court Disposition

Interlocutory injunctions/applications for interlocutory relief refused; Hexal's notice of motion dismissed; application for relief against Alphapharm refused.

Orders

  • ['The notice of motion filed on 1 July 2005 by Roche in NSD 984/2005 (against Hexal) is dismissed.' 'The application for interlocutory relief by Roche in NSD 1209/2005 (against Alphapharm) is refused.']